Pharma majors gear up to launch molnupiravir
The Hindu
DCGI nod for emergency use spurs consortium production
Cipla, Sun Pharma and Dr. Reddy’s Laboratories were among the clutch of pharma firms that on Tuesday said they will soon be launching molnupiravir capsules.
Their announcement followed emergency use authorisation for the oral anti-viral drug from the Drugs Controller General of India (DCGI). Most of the firms had entered into a non-exclusive voluntary licensing agreement with Merck Sharpe Dohme (MSD) to manufacture and supply molnupiravir in India and to over 100 low and middle-income countries (LMICs).
Torrent Pharma, Hetero, Optimus Pharma and Natco Pharma were the other companies that said they have received the DCGI approval and are gearing up to launch the oral drug.
YouTuber ‘Savukku’ Shankar alias A. Shankar’s mother has filed a habeas corpus petition (HCP) challenging his detention under the Goondas Act even before the Home Secretary could refer the matter to the Advisory Board for its opinion and therefore, the petition must be dismissed, Greater Chennai City Commissioner of Police Sandeep Rai Rathore, has contended before the Madras High Court.